Efficacy of Various Scoring Systems for Predicting the 28-Day Survival Rate among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Emergency Intensive Care
Table 1
Comparison of clinical data between the survival and death groups of patients with AECOPD.
Survival group ()
Death group ()
Statistical magnitude ()
value
Gender (male/female)
214/122
26/20
0.19
0.505
Age (years)
77.43 ± 10.96
−2.52
0.013
History of COPD (years)
13.8 ± 5.4
14.3 ± 5.6
0.95
0.35
Smoking (%)
189 (56.2)
27 (59.2)
0.38
0.54
BMI (kg/m2)
23.42 ± 2.81
22.71 ± 3.91
1.07
0.29
Temperature (°C)
36.59 ± 0.69
36.73 ± 0.84
−0.82
0.41
Pulse (times/min)
106 ± 15
112 ± 20
−1.27
0.22
Breathing (times/min)
21.2 ± 4.9
20.2 ± 3.1
0.96
0.33
SAP (mmHg)
139.4 ± 27.0
135.0 ± 28.8
0.72
0.47
DAP (mmHg)
76.9 ± 14.4
71.7 ± 19.7
1.54
0.12
MAP (mmHg)
97.8 ± 16.5
92.8 ± 20.2
1.30
0.19
GCS score
14.8 ± 0.8
12.0 ± 3.5
3.88
0.001
Renal inadequacy
74 (22.0)
16 (34.8)
3.657
0.056
Hypertension
96 (28.6)
20 (43.5)
4.252
0.039
Coronary heart disease
78 (23.2)
18 (39.1)
5.448
0.020
Diabetes
116 (34.5)
16 (34.8)
0.001
0.972
Cerebrovascular disease
68 (20.2)
14 (30.4)
2.495
0.114
Heart failure
54 (16.1)
30 (65.2)
56.969
<0.001
Arrhythmia
0 (0)
12 (26.1)
90.495
<0.001
Anemia
14 (4.2)
8 (17.4)
13.038
0.002
Gastrointestinal bleeding
8 (2.4)
2 (4.3)
0.614
0.344
Malnutrition
158 (47.0)
18 (39.1)
1.015
0.314
Fracture leading to bedridden status
4 (1.2)
4 (8.7)
11.115
0.001
Liver dysfunction
12 (3.6)
4 (8.7)
2.647
0.104
Tumor
2 (0.6)
12 (26.1)
74.470
<0.001
Pulmonary embolism
6 (1.8)
0 (0)
0.835
0.361
Thrombocytopenia
2 (0.6)
0 (0)
0.275
0.600
BMI, body mass index; COPD, chronic obstructive pulmonary disease; GCS, Glasgow coma scale; SAP, systolic arterial pressure; DAP, diastolic arterial pressure; MAP, mean arterial pressure.
